Changes in biogenic amine content in various parts of the rat brain after administration of morphine and amobarbital
โ Scribed by B. M. Kogan; N. V. Nechaev
- Publisher
- Springer US
- Year
- 1979
- Tongue
- English
- Weight
- 243 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Male, Wistar rats were injected into the right lateral ventricle of the brain with 250 ~g of 6-hydroxy-dopamine (6-OHDA). The behaviour of animals and the level of noradrenaline (NA), dopamine (DA) and 5-hydroxytryptamine (5-HT) were measured after different periods of time. During the first hour af
Pyrroxan (20 mg/kg, i.p.) , a new potential antianxiety agent, increased brain norepinephrine (NE) turnover in rats, reflecting a possible central e-adrenergic receptor blocking activity, in contrast, chlordiazepoxide (20 mg/kg, i.p.), a widely used antianxiety agent, did not alter the NE turnover.
This study was conducted to determine the uptake of dihydroergotamine (DHE) into the brain after intravenous and intranasal administration in rats. Eight anesthetized rats received either an intravenous (i.v.) or two successive intranasal (i.n.) doses of tritium labeled dihydroergotamine ( 3 H-DHE)
The proteolytic enzyme, papain, was given systematically to evaluate the short-and long-term effects of inhibition of endochondral bone formation on pelvic growth, with emphasis on the innominate bone. Ninety-eight Lewis-strain male rats, used concurrently for craniofacial growth studies, were divid